The biomarkers of potential harm in Ploom Tech users were closer to those of never-smokers than they were to those of combustible cigarette smokers, according to a recent study cited by Japan Tobacco.
The study was conducted in consultation with Yuji Kumagai, professor at the Kitasato Clinical Research Center.
“Although further research is required, this new clinical study again highlights that Ploom Tech has the potential of reducing the health risks associated with smoking,” said Ian Jones, vice president and R&D principal scientist at Japan Tobacco International.